125I粒子条胆道腔内放射联合胆道支架植入术治疗恶性梗阻性黄疸

肝脏 ›› 2023, Vol. 28 ›› Issue (5): 581-584.

¹²⁵I粒子条胆道腔内放射联合胆道支架植入术治疗恶性梗阻性黄疸

吕冠海, 陈瑞文, 魏强

231007 安徽理工大学第一附属医院(淮南市第一人民医院)介入放射科

收稿日期:2022-11-05 出版日期:2023-05-31 发布日期:2023-08-29
通讯作者: 陈瑞文,Email:crw1125@sina.com
基金资助:
淮南市科技计划项目(2018A3613)

Clinical study of 125 iodine particle strip biliary cavity radiation combined with biliary stent implantation in the treatment of malignant obstructive jaundice

LV Guan-hai, CHEN Rui-wen, WEI Qiang

Department of Interventional Radiology, the First Affiliated Hospital of Anhui University of Technology (Huainan First People's Hospital), Anhui 231007, China

Received:2022-11-05 Online:2023-05-31 Published:2023-08-29
Contact: CHEN Rui-wen,Email:crw1125@sina.com

摘要/Abstract

摘要： 目的研究¹²⁵I粒子条胆道腔内放射联合胆道支架植入术治疗恶性梗阻性黄疸的临床效果。方法选取淮南市第一人民医院2017年5月至2021年10月就诊的恶性梗阻性黄疸患者56例,按治疗方法将其分成对照组15例,研究组41例。比较两组总生存时间、肝功能、并发症、临床疗效、支架通畅时间。结果两组术后4周的直接胆红素(DBil)、丙氨酸转氨酶(ALT)、天冬氨酸转氨酶(AST)以及总胆红素(TBil)均低于术前(P<0.05),但两组术后4周的ALT、TBil、DBil、AST比较差异无统计学意义(P＞0.05)。研究组、对照组临床成功率分别为95.12%(39/41)、14/15例,差异无统计学意义(P＞0.05)。对照组、研究组总并发症发生率分别为2/15例、14.63%(6/41),差异无统计学意义(P＞0.05)。研究组、对照组中位支架通畅时间分别为241 d、147 d,研究组支架通畅时间函数优于对照组(P<0.05)。对照组、研究组中位生存时间分别为165 d、253 d,研究组总生存函数优于对照组(P<0.05)。结论胆道支架植入术联合¹²⁵I粒子条胆道腔内放射治疗可延长恶性梗阻性黄疸患者总生存时间与支架通畅时间,疗效显著,改善患者肝功能,且安全可靠。

关键词: 胆道支架植入术, ¹²⁵I粒子条, 胆道腔内放射, 恶性梗阻性黄疸, 临床疗效

Abstract: Objective To study the clinical effect of 125 iodine particle strips combined with biliary stents in the treatment of malignant obstructive jaundice.Methods 56 patients with malignant obstructive jaundice from May 2017 to October 2021 were selected and divided into control group (15 cases) and study group (41 cases).In the two groups,the overall survival time, liver function, complications, clinical efficacy and stent patency time were compared.Results Direct bilirubin (DBIL),alanine aminotransferase (ALT),aspartate aminotransferase (AST) and alanine aminotransferase (ALT) levels of 4 weeks after surgery were lower than before surgery (P<0.05), but there were no differences in ALT, TBIL, DBIL and AST 4 weeks after surgery between the two groups (P>0.05). The clinical success rates of the study group and the control group were 95.12% and 93.33%, respectively, with no difference (P>0.05). The total complication rates of the control group and the study group were 13.33% and 14.63%, respectively, with no difference (P>0.05). The median stent patency time of the study group and the control group were 241 d and 147 d, respectively, and the study group with function of stent patency time was better than control group (P<0.05). The median survival time of the control group and the research group was 165 d and 253 d, respectively, and the study group with total survival function was better than control group (P<0.05).Conclusion Biliary stent implantation combined with biliary cavity radiotherapy with 125 iodine particle strips can prolong the overall survival time and stent patency time of patients with malignant obstructive jaundice, which is effective, improves liver function, and is safe and reliable.

Key words: Biliary stent implantation, 125 iodine particle bar, Intravascular radiation of biliary tract, Malignant obstructive jaundice, Clinical curative effect

吕冠海, 陈瑞文, 魏强. ¹²⁵I粒子条胆道腔内放射联合胆道支架植入术治疗恶性梗阻性黄疸[J]. 肝脏, 2023, 28(5): 581-584.

LV Guan-hai, CHEN Rui-wen, WEI Qiang. Clinical study of 125 iodine particle strip biliary cavity radiation combined with biliary stent implantation in the treatment of malignant obstructive jaundice[J]. Chinese Hepatolgy, 2023, 28(5): 581-584.

参考文献

[1] 徐璐. PTBD与PTIBS治疗低位恶性梗阻性黄疸的效果观察. 肝胆外科杂志,2022,30(4):288-291.
[2] 李秀轻,李佳璇,王桂春,等. PICC与CVC在恶性梗阻性黄疸行LPD患者中的效果分析. 河北医药,2022,44(4):571-573,577.
[3] Wang HW, Li XJ, Li SJ, et al. Biliary stent combined with iodine-125 seed strand implantation in malignant obstructive jaundice. World J Clin Cases,2021,9(4):801-811.
[4] Wang HB, Peng F, Wang M, et al. Impact of percutaneous transhepatic biliary drainage on clinical outcomes of patients with malignant obstructive jaundice undergoing laparoscopic pancreaticoduodenectomy. Curr Med Sci,2021,41(2):375-380.
[5] Scheufele F, Aichinger L, Jager C, et al. INR and not bilirubin levels predict postoperative morbidity in patients with malignant obstructive jaundice. Am J Surg,2021,222(5):976-982.
[6] Kong YL, Zhang HY, Liu CL, et al. Improving biliary stent patency for malignant obstructive jaundice using endobiliary radiofrequency ablation: experience in 150 patients. Surg Endosc,2022,36(3):1789-1798.
[7] 宋玉昕,吕洪章,张玲玲,等. 携带碘125粒子食管支架治疗食管癌的临床研究. 现代肿瘤医学,2020,28(10):1663-1667.
[8] Xiang Y, Lu S, Li Y, et al. Iodine-125 seeds combined with biliary stent placement versus stent placement alone for unresectable malignant biliary obstruction: a meta-analysis of randomized controlled trials. J Cancer,2021,12(5):1334-1342.
[9] 中国抗癌协会肿瘤介入学专业委员会. 梗阻性黄疸经皮肝穿刺胆道引流及支架植入术专家共识(2018). 临床肝胆病杂志,2019,35(3):504-508.
[10] Li J, Yu T, Zhang L, et al. An iodine-125 seed strand combined with a metal stent versus a metal stent alone for obstructive jaundice caused by pancreatic ductal adenocarcinoma. Brachytherapy,2021,20(2):446-453.
[11] 马博,周军,周京涛,等. 胆道支架植入治疗恶性梗阻性黄疸术后并发症的发生因素分析. 现代生物医学进展,2021,21(7):1283-1286.
[12] 罗君,邵国良. 单纯胆道支架与支架联合125I粒子条植入治疗恶性梗阻性黄疸:一项回顾性对照研究. 介入放射学杂志,2021,30(12):1256-1260.
[13] 彭赵宏,施万印,赵本胜,等. 比较两种不同粒子条制作及植入方法联合胆道支架治疗恶性梗阻性黄疸. 介入放射学杂志,2021,30(9):899-904.
[14] 庄志泉,马婧嶔,罗剑钧,等. 碘-125粒子条联合胆道金属支架植入治疗恶性梗阻性黄疸的长期疗效及预后因素分析. 复旦学报(医学版),2021,48(3):300-306.
[15] 徐红豆,吴军政,周卫忠,等. 经皮胆道支架和125I粒子条腔内植入联合动脉灌注化疗治疗恶性梗阻性黄疸的疗效分析. 介入放射学杂志,2021,30(9):905-910.
[16] 袁倩倩,杨森,白云玲,等. 食管125I粒子支架姑息治疗晚期食管癌剂量学参数与疗效的关系. 中南医学科学杂志,2022,50(1):63-66.
[17] 徐红豆,周卫忠,刘圣,等. 经皮胆道支架联合125I粒子条腔内植入治疗恶性梗阻性黄疸的疗效分析. 介入放射学杂志,2020,29(1):83-88.
[18] 沈海洋,周中华,宋浩,等. 胆道支架联合引流管置入125I粒子条治疗恶性梗阻性黄疸. 中国介入影像与治疗学,2022,19(7):401-405.
[19] Wang T, Liu S, Zheng Y B, et al. Clinical study on using (125)I seeds articles combined with biliary stent implantation in the treatment of malignant obstructive jaundice. Anticancer Res,2017,37(8):4649-4653.
[20] Hasimu A, Gu J P, Ji W Z, et al. Comparative study of percutaneous transhepatic biliary stent placement with or without Iodine-125 seeds for treating patients with malignant biliary obstruction. J Vasc Interv Radiol,2017,28(4):583-593.

¹²⁵I粒子条胆道腔内放射联合胆道支架植入术治疗恶性梗阻性黄疸

Clinical study of 125 iodine particle strip biliary cavity radiation combined with biliary stent implantation in the treatment of malignant obstructive jaundice

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 11

编辑推荐

Metrics

本文评价

[1]	汪洋, 徐震, 王正, 潘智. ERCP与LBEPS分别联合LC治疗胆囊合并胆总管结石临床疗效比较[J]. 肝脏, 2023, 28(1): 108-111.
[2]	薛芮, 范建高. FXR激动剂治疗非酒精性脂肪性肝炎的现状及展望[J]. 肝脏, 2021, 26(8): 835-837.
[3]	张均维, 黄旭东, 蔡弟, 王桂浩. 巨大肝血管瘤患者临床特征及不同介入栓塞材料的价值观察[J]. 肝脏, 2021, 26(7): 788-791.
[4]	郭萍, 袁志平. 三维适形放疗联合TACE治疗中晚期肝癌患者的早期疗效[J]. 肝脏, 2020, 25(12): 1269-1271.
[5]	张伟华, 秦艳青, 沈金杰. IRE联合NK细胞治疗原发性肝癌的安全性和临床疗效[J]. 肝脏, 2020, 25(12): 1272-1274.
[6]	袁小凌, 白玉盘, 尹东林, 洪晟镇, 包玉洁, 周园园, 焉雷, 康耀月, 范珊, 曹俊英, 许洁. SII、NLR对于恶性梗阻性黄疸患者PTCD胆道金属支架置入术后生存时间的影响[J]. 肝脏, 2018, 23(6): 492-495.
[7]	陶英杰. 胆宁片对非酒精性脂肪肝患者血生化指标影响及临床疗效分析[J]. 肝脏, 2018, 23(1): 65-68.
[8]	唐敏,向君华,赵荣,谈娅娟. 小儿慢性乙型肝炎应用干扰素α-1b的疗效观察[J]. 肝脏, 2017, 22(8): 744-746.
[9]	钟岳, 汪庆强, 慕喜喜, 张震波, 杨福泉, 冯伟. 经皮射频消融与手术切除治疗小肝癌的临床疗效比较[J]. 肝脏, 2017, 22(7): 623-625.
[10]	戴春,谭明,耿兴荣,黄良平,于永进. 三孔法在急诊胆囊腹腔镜手术中的应用及临床疗效[J]. 肝脏, 2017, 22(12): 1133-1135.
[11]	马思聪, 王涛, 丁敏, 明雅南, 戚星星, 张源, 翟博. 超声引导下微波消融一线治疗原发性肝癌:临床疗效以及预后影响因素[J]. 肝脏, 2016, 21(5): 355-359.